• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Cardiac Dimensions Inc.

Cardiac Dimensions raises $53M for mitral contour system

March 20, 2025 By Sean Whooley

Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million. Ally Bridge Group led the Series E round, while new investor Claret Capital Partners joined in. Existing investors also provided significant participation. That list includes Hostplus, M.H. Carnegie, Horizon 3 Healthcare, Lumira Ventures and a confidential strategic investor. The […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Funding Roundup, Implants, Structural Heart Tagged With: Cardiac Dimensions, Cardiac Dimensions Inc., nitinol

Cardiac Dimensions has a new chief medical officer

January 16, 2024 By Sean Whooley

Cardiac Dimensions announced today that it appointed Dr. Satya Shreenivas as its new chief medical officer (CMO). Kirkland, Washington-based Cardiac Dimensions develops minimally invasive treatments for heart failure with functional mitral regurgitation (FMR). That includes the Carillon Mitral Contour System, for which the company has the ongoing EMPOWER trial. Its new CMO served as an […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Structural Heart Tagged With: Cardiac Dimensions, Cardiac Dimensions Inc., Personnel Moves

Cardiac Dimensions raises $35M Series D for mitral contour system

January 5, 2023 By Sean Whooley

Heart failure treatment developer Cardiac Dimensions announced today that closed a $35 million Series D financing round. Kirkland, Washington-based Cardiac Dimensions develops minimally invasive treatment modalities for heart failure and related cardiovascular conditions. Its lead product, the Carillon Mitral Contour System, uses a gentle, minimally invasive approach. It designed the system to restore natural mitral […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Funding Roundup, News Well, Structural Heart Tagged With: Cardiac Dimensions, Cardiac Dimensions Inc.

Cardiac Dimensions touts Carillon TMVR study

September 12, 2019 By Sean Whooley

Cardiac Dimensions today touted a clinical study of its Carillon mitral contour system in treating the primary cause of functional mitral regurgitation (FRM) in patients with heart failure. Carillon is a right heart transcatheter mitral valve repair (TMVR) device designed to treat FRM in patients with mitral regurgitation grades of 2+, 3+ and 4+ in […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Clinical Trials, Featured, News Well Tagged With: Cardiac Dimensions Inc.

Cardiac Dimensions touts data from Carillon TMVR device study

April 26, 2019 By Fink Densford

Cardiac Dimensions today released results from a trial of its Carillon mitral contour system intended for treating functional mitral regurgitation in patients with heart failure, touting significant reductions in regurgitant volume after implantation. Results from the trial were presented at the German Society of Cardiology annual congress, the Kirkland, Wash.-based company said. The percutaneous Carillon device […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Featured Tagged With: Cardiac Dimensions Inc.

Aegea Medical picks up former Cardiokinetix, Concentric Medical CEO Sainz | Personnel Moves – May 14, 2018

May 14, 2018 By Fink Densford

Aegea Medical said last week it tapped former Cardiokinetix prez & CEO Maria Sainz as its new president and chief executive officer, effective immediately. Sainz will replace former CEO Don Gurskis, who has held the corner office since 2013. Gurskis will remain on as member of the Redwood City, Calif.-based company’s executive management team. “Maria is […]

Filed Under: Business/Financial News Tagged With: ACell, aegeamedical, Boston Scientific, Cardiac Dimensions Inc., CardioKinetix Inc., cellectbiotechnology, Cerus Corp., Concentric Medical Inc., Conventus Orthopaedics, Cordis Corp., Covidien, GE Healthcare, Guidant Corp., Hillrom, InfraReDx Inc., Nellix Inc., Nipro, Personnel Moves, sciton, Sensus Healthcare LLC, Stryker, Viveve Medical

Cardiac Dimensions anchors $39m Series B for Carillon mitral repair device

April 26, 2018 By Brad Perriello

Cardiac Dimensions said today that it raised a $39 million Series B round for the Carillon mitral valve repair device it’s developing. Kirkland, Wash.-based Cardiac Dimensions said the round was led by a new Australian backer, Hostplus, and included a venture debt contribution from Oxford Finance. Existing investors M. H. Carnegie, Arboretum Ventures, Lumira Capital, LSP Health […]

Filed Under: Funding Roundup, Replacement Heart Valves, Wall Street Beat Tagged With: Cardiac Dimensions Inc.

FDA approves Cardiac Dimensions trial for Carillon mitral repair device

December 1, 2016 By Brad Perriello

Cardiac Dimensions said today that the FDA granted an investigational device exemption for a pivotal trial of its Carillon mitral valve repair device. Kirkland, Wash.-based Cardiac Dimensions said the 400-patient study will compare the device with guideline-directed treatment of symptomatic functional mitral regurgitation associated with heart failure after a year. The percutaneous Carillon annuloplasty device is designed […]

Filed Under: Cardiovascular, Clinical Trials, Replacement Heart Valves Tagged With: Cardiac Dimensions Inc.

Cardiac Dimensions touts small Carillon mitral repair study

February 24, 2016 By Brad Perriello

Cardiac Dimensions today touted the publication of a small study of its Carillon mitral valve repair system in the Journal of Invasive Cardiology, saying the device led to significant improvement in patients with functional mitral regurgitation. The percutaneous Carillon annuloplasty device is designed to use a distal anchor and proximal anchor, connected by a shaping ribbon, to reshape the […]

Filed Under: Cardiovascular, Clinical Trials, Replacement Heart Valves Tagged With: Cardiac Dimensions Inc.

Cardiac Dimensions taps ex-AccessClosure chief Casciaro for CEO | Personnel Moves

December 17, 2015 By Brad Perriello

Cardiac Dimensions said this week that it tapped the former chief of AccessClosure, Gregory Casciaro, to be its new president & CEO. Casciaro led AccessClosure until its May 2014 acquisition by Cardinal Health (NYSE:CAH) for $320 million. His résumé includes stints as the chief executive at drug-eluting stent maker Xtent, Orquest (acquired JNJ’s DePuy Acromed in 2003) […]

Filed Under: Business/Financial News Tagged With: Cardiac Dimensions Inc., Cellnovo, Delphinus Medical Technologies Inc., dextera, Femasys Inc., Grifols, Masimo, NVision, Personnel Moves, Procyrion, Signostics

Cardiac Dimensions touts cost-utility study of Carillon mitral valve

September 10, 2015 By Fink Densford

Cardiac Dimensions said yesterday a new cost-utility study of its Carillon mitral valve shows it to be a cost-effective alternative when compared to optimal medical treatment for treating functional mitral regurgitation. The study was published in the journal BMC Cardiovascular Disorders, and analyzed data from the Titan clinical trial. The study reported an incremental cost-effectiveness ratio […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular Tagged With: Cardiac Dimensions Inc.

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy